• Mashup Score: 0

    A patient presents with nuclear sclerosis, fluctuating vision, and a history of eight-incision centripetal radial keratotomy.

    Tweet Tweets with this article
    • A patient presents with nuclear #sclerosis, fluctuating vision, and a history of eight-incision centripetal radial #keratotomy. Read the case: https://t.co/AUIey3n5fC https://t.co/q8XG1W5AHy

  • Mashup Score: 0

    Objectives Systemic sclerosis (SSc) is characterised by extensive tissue fibrosis maintained by mechanotranductive/proadhesive signalling. Drugs targeting this pathway are therefore of likely therapeutic benefit. The mechanosensitive transcriptional co-activator, yes activated protein-1 (YAP1), is activated in SSc fibroblasts. The terpenoid celastrol is a YAP1 inhibitor; however, if celastrol can…

    Tweet Tweets with this article
    • What is new on the treatment of #systemic #sclerosis? ▶️ celastrol impairs fibrotic phenotype of fibroblasts ▶️ celastrol counteracts bleomycin-induced gene expression programmes ▶️ celastrol antagonise the mechanosensitive YAP pathway 🔗 https://t.co/y499g49s6W

  • Mashup Score: 0

    Obstructive sleep apnea had a significant effect on perceived problems with cognitive function in women with multiple sclerosis, according to study results published in Multiple Sclerosis Journal.“Our findings provide new evidence to suggest that sleep disorders may play a pivotal role in the development of cognitive problems in women with multiple sclerosis [MS],” Tiffany J. Braley,

    Tweet Tweets with this article
    • Published in @MSJ_Research: Obstructive sleep apnea (#OSA) had a significant effect on perceived problems with #cognitive function in women with multiple #sclerosis. @healiowomen @healioneurology https://t.co/lXgF4zTtfp

  • Mashup Score: 0

    For diagnosing systemic sclerosis-related ILD, Krebs von den Lungen-6, surfactant protein-D and interleukin-8 in blood/bronchoalveolar lavage fluid samples were found to be “reliable biomarkers,” according to results published in Thorax.“Systemic sclerosis (SSc) is a rare but severe auto-immune disease that is poorly understood,” Bettina C. Schock, PhD, lecturer at The

    Tweet Tweets with this article
    • Published in @ThoraxBMJ: For diagnosing systemic #sclerosis-related #ILD, Krebs von den Lungen-6, surfactant protein-D and interleukin-8 in blood/bronchoalveolar lavage fluid samples were found to be “reliable biomarkers.” @HealioRheum https://t.co/b8gBkFQx2F

  • Mashup Score: 1

    A composite biomarker index could improve the risk stratification and diagnosis of interstitial lung disease in patients with systemic sclerosis, according to data published in Arthritis & Rheumatology. “ILD is detectable in up to 80% of patients with systemic sclerosis (SSc), and a leading cause of morbidity and mortality,” Adelle S. Jee, PhD, of the department of respiratory

    Tweet Tweets with this article
    • ICYMI: A composite biomarker index could improve the #risk stratification and diagnosis of interstitial lung disease in patients with systemic #sclerosis @rpahos_school #RheumTwitter https://t.co/aT6g2lb1bg

  • Mashup Score: 0

    A composite biomarker index could improve the risk stratification and diagnosis of interstitial lung disease in patients with systemic sclerosis, according to data published in Arthritis & Rheumatology. “ILD is detectable in up to 80% of patients with systemic sclerosis (SSc), and a leading cause of morbidity and mortality,” Adelle S. Jee, PhD, of the department of respiratory

    Tweet Tweets with this article
    • A composite biomarker index could improve the #risk stratification and diagnosis of interstitial lung disease in patients with systemic #sclerosis @rpahos_school #RheumTwitter https://t.co/aT6g2lb1bg

  • Mashup Score: 1

    Patients diagnosed with systemic sclerosis-related pulmonary hypertension in the last 10 years had better survival than those diagnosed prior, according to results published in American Journal of Respiratory and Critical Care Medicine.“We believe that with combined therapy, patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) may have much better response

    Tweet Tweets with this article
    • “The future for pulmonary arterial hypertension, and particularly systemic #sclerosis-associated #PAH is upfront combination (dual or triple) therapy,” Paul M. Hassoun, MD, at @HopkinsMedicine, told Healio. https://t.co/g1cS4Y4l9y